ESR2 and breast neoplasm: A number of clinical studies have revealed that the presence of ERβ protein in breast tumors correlates with improved rates of recurrence, disease-free survival and overall survival [29-38] while others indicate little correlation [39-41] or even worse prognosis [42,43].